This Stock Should Soar If the Stock Market Crashes This Summer

You might not have heard of Harry Dent Jr. He’s an American author, economist, and investment firm founder who correctly predicted the Japanese economic downturn in 1989. He also forecast the dot.com bubble’s collapse. 

© Provided by The Motley Fool This Stock Should Soar If the Stock Market Crashes This Summer

Dent now believes that the stock market will crash within the next three months, with a good chance that it could happen before the end of July. And he doesn’t think it will be a minor downturn. He recently stated in an interview with financial publication ThinkAdvisor that this “will be the biggest crash of our lifetime.” 

There’s no way to know if Dent’s pessimistic outlook is warranted at this point. However, even if he’s right, I don’t think that every stock will plunge. There’s at least one stock that should soar if the stock market crashes this summer.

© Getty Images Two blocks with down arrow and dollar sign, and hand adding third block with up arrow.

Most likely culprit behind a crash

Dent thinks that the housing price bubble will pop and serve as the initial cause of a near-term stock market crash. I don’t find that argument all that convincing. Interest rates remain near historic lows. The inventory of homes for sale is still well below the demand. Mortgage capital provider Freddie Mac expects the housing market to remain strong throughout this year.

Load Error

If a market crash is on the way within the next few months as Dent predicts, my take is that there’s a much more likely culprit — the rise of coronavirus variants. This shouldn’t be surprising considering that the coronavirus caused the most recent stock market crash a little over a year ago.

We’re already seeing COVID-19 cases rise throughout the world, in large part because of the spread of the delta variant first identified in India. Just last week, several countries in Europe issued new travel restrictions as a result of concerns about this coronavirus variant.

One of the key drivers for the tremendous recovery for stocks after the sell-off in early 2020 was the expectation that the economic effect of the pandemic would be short-lived. Many investors have been banking on a widespread economic reopening. There’s a possibility that new variants could dash those hopes and set the stage for another market meltdown.

The biggest beneficiary

My view is that vaccine stocks would likely take off if coronavirus variants cause a market crash within the next few months. After all, vaccines would be the best chance of beating the variants. I also believe that BioNTech (NASDAQ: BNTX) would be the biggest winner in the group.

Why BioNTech? For one thing, it’s by far the smallest of the companies that currently have vaccines on the market. Catalysts usually generate bigger swings in stocks with smaller market caps than they do with those with larger market caps.

I think that it’s important that BioNTech and its partner, Pfizer (NYSE: PFE), are already working on strategies to address the rise of the delta variant. The two companies believe that a third dose of their COVID-19 vaccine could provide more protection against this coronavirus strain. They also plan to begin clinical testing in August of a modified version of the vaccine that specifically targets the delta variant. 

There’s also the matter of valuation. BioNTech is the cheapest of the leading vaccine stocks right now, based on forward earnings multiples. The biotech’s shares trade at only 6.3 times expected earnings. I wouldn’t expect that low valuation to last very long if fears about coronavirus variants increase so much that there’s a huge market downturn.

A dent in the doomsaying

Now for a critical disclaimer: I don’t think Dent’s prediction of an imminent stock market crash will come true. It’s not that there’s no chance that he could be right; my view is just that it’s unlikely that he will be.

I’ve already discussed why I don’t agree with his take that the housing market bubble will precipitate a crash is on point. And while I do believe that the rise of coronavirus variants would be the most likely cause of a near-term market plunge, I nonetheless don’t expect it to happen.

It’s important to understand that the currently available COVID-19 vaccines are still highly effective at preventing severe disease — even against the delta variant. The main problem, as I see it, with the rise in COVID-19 cases is that too few people have been fully vaccinated. However, enough individuals have been fully vaccinated that I don’t expect a return of the lockdowns we saw last year. 

Also, with all due respect to Harry Dent, he’s been wrong quite a bit in the past. As a case in point, he published a book titled The Great Depression Ahead in early 2009. In this book, he predicted a major economic depression that could last for a decade or more. History didn’t treat that prediction kindly.  

SPONSORED:

10 stocks we like better than BioNTech SE

When our award-winning analyst team has a stock tip, it can pay to listen. After all, the newsletter they have run for over a decade, Motley Fool Stock Advisor, has tripled the market.*

They just revealed what they believe are the ten best stocks for investors to buy right now… and BioNTech SE wasn’t one of them! That’s right — they think these 10 stocks are even better buys.

See the 10 stocks

 

*Stock Advisor returns as of June 7, 2021

 

Keith Speights owns shares of Pfizer. The Motley Fool has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy.

Continue Reading